logo

GANX

Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)

GANX fundamentals

Gain Therapeutics (GANX) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.19 (YoY +54.76%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.19
+54.76%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.
EPS
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.31-0.3-0.39-0.2687-0.28-0.43-0.38-0.39-0.43-0.62-0.37-0.29-0.22-0.42-0.17-0.08-0.16-0.19
Forecast
-0.3167-0.2656-0.3551-0.4808-0.3478-0.3025-0.4475-0.3648-0.394-0.3079-0.446-0.312-0.3108-0.1948-0.2072-0.1837-0.1798-0.1667
Surprise
+2.12%
-12.95%
-9.83%
+44.11%
+19.49%
-42.15%
+15.08%
-6.91%
-9.14%
-101.36%
+17.04%
+7.05%
+29.21%
-115.61%
+17.95%
+56.45%
+11.01%
-13.98%
Revenue
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
5.30K89.17K27.34K43.00K45.01K95.10K0055.18K000000000
Forecast
----20.00K51.60K39.00K31.67K51.50K010.00K1.01M337.50K250.00K120.00K400.00K10.00K025.00K0
Surprise
0.00%
0.00%
+36.73%
-16.67%
+15.40%
+200.32%
-100.00%
0.00%
+451.80%
-100.00%
-100.00%
-100.00%
-100.00%
-100.00%
-100.00%
0.00%
-100.00%
0.00%

Earnings Call